# NANOMIX Corp

NANOMIX Corp is a company headquartered in Lawrence, MA, United States.

## Company overview

- **Legal name:** NANOMIX Corp
- **Former names in filing history:** Boston Therapeutics, Inc. (2010-03-08 to 2021-11-05); AVANYX Therapeutics, Inc. (2010-02-08 to 2010-11-23)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Lawrence, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001473579

## About

NANOMIX Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001473579, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-04-07, it reported annual revenue of USD 15,450; total assets of USD 982,055 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $15,450 (USD 15,450)
- **Total assets:** $982,055 (USD 982,055)
- **Operating cash flow:** -$6.1M (USD -6,085,990)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $141,778 (USD 141,778)
- **Total assets:** $905,712 (USD 905,712)
- **Cash and equivalents:** $297,351 (USD 297,351)
- **Operating cash flow:** -$6.3M (USD -6,317,589)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $9,336 (USD 9,336)
- **Net income:** -$907,883 (USD -907,883)
- **Total assets:** $19,900 (USD 19,900)
- **Cash and equivalents:** $7,402 (USD 7,402)
- **Operating cash flow:** -$784,299 (USD -784,299)
- **Later filings:** Revenue, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $16,329 (USD 16,329)
- **Net income:** -$3.7M (USD -3,694,079)
- **Total assets:** $23,781 (USD 23,781)
- **Cash and equivalents:** $6,701 (USD 6,701)
- **Operating cash flow:** -$1.2M (USD -1,195,938)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2023-11-24 — period 2023-11-02 — CURRENT REPORT
- Form 10-K — filed 2023-04-07 — period 2022-12-31 — ANNUAL REPORT
- Form 8-K — filed 2023-03-10 — period 2023-03-10 — FORM 8-K
- Form 8-K — filed 2023-01-25 — period 2023-01-19 — CURRENT REPORT
- Form 10-Q — filed 2022-11-14 — period 2022-09-30 — QUARTERLY REPORT
- Form 8-K — filed 2022-11-10 — period 2022-10-21 — CURRENT REPORT
- Form 8-K — filed 2022-09-09 — period 2022-08-31 — CURRENT REPORT
- Form 10-Q — filed 2022-08-15 — period 2022-06-30 — QUARTERLY REPORT
- Form 8-K — filed 2022-07-29 — period 2022-07-22 — CURRENT REPORT
- Form S-1 — filed 2022-06-21 — REGISTRATION STATEMENT
- Form 10-Q — filed 2022-05-17 — period 2022-03-31 — QUARTERLY REPORT
- Form 8-K — filed 2022-05-10 — period 2022-03-30 — CURRENT REPORT

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/nanomix-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology